Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trialAJOG Global Reports at a Glance
BACKGROUND: Recent studies have reported higher risks of adverse maternal and neonatal outcomes, such as hypertensive disorders of pregnancy, after programmed frozen embryo transfer, especially in cycles with gonadotropin-releasing hormone agonist pretreatment. It remains unclear if GnRH agonist pre...
Saved in:
Main Authors: | Hui-ying Jie, MD (Author), Ruifang Hu, BS (Author), Limei Zhang, MD (Author), Kexin Dong, MD (Author), Chunyan Wu, MD (Author), Qiong Wang, MD (Author), Lu Luo, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012) -
Clinical development of the GnRH agonist leuprolide acetate depot
by: Kristof Chwalisz, M.D., Ph.D
Published: (2023) -
Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
by: Hwu Yuh-Ming, et al.
Published: (2009) -
GnRH agonists in the treatment of symptomatic endometriosis: a reviewEssential Points
by: Eric S. Surrey, M.D
Published: (2023) -
Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
by: Alamtaj Samsami, et al.
Published: (2020)